{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:12:11Z","timestamp":1761513131378},"reference-count":0,"publisher":"BMJ","issue":"may11 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[2012,5,11]]},"DOI":"10.1136\/bmj.e3343","type":"journal-article","created":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T11:18:52Z","timestamp":1336735132000},"page":"e3343-e3343","source":"Crossref","is-referenced-by-count":6,"title":["Abbott pays $1.6bn for promoting off label use of valproic acid"],"prefix":"10.1136","volume":"344","author":[{"given":"B.","family":"Roehr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2012,5,11]]},"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.e3343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T21:52:22Z","timestamp":1601070742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.e3343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,11]]},"references-count":0,"journal-issue":{"issue":"may11 1","published-online":{"date-parts":[[2012,5,11]]},"published-print":{"date-parts":[[2012,5,11]]}},"URL":"https:\/\/doi.org\/10.1136\/bmj.e3343","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,11]]}}}